Clinical relevance of biomarkers for the identification of patients with carotid atherosclerotic plaque: Potential role and limitations of cysteine protease legumain

Atherosclerosis. 2017 Feb:257:248-249. doi: 10.1016/j.atherosclerosis.2017.01.003. Epub 2017 Jan 18.

Authors

Enrico Ammirati¹, Federica Fogacci²

Affiliations

¹ De Gasperis" Cardio Center, Niguarda Hospital, Milan, Italy; San Raffaele Vita-Salute University, Milan, Italy. Electronic address: ammirati.enrico@hsr.it.
² Medical and Surgical Sciences Department, University of Bologna, Bologna, Italy. Electronic address: federicafogacci@gmail.com.

PMID: 28126320
DOI: 10.1016/j.atherosclerosis.2017.01.003

No abstract available

Keywords: Atherosclerosis; Biomarkers; Carotid plaque; Legumain; Protease.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers
Carotid Artery Diseases*
Cysteine Endopeptidases
Cysteine Proteases
Humans
Plaque, Atherosclerotic*

Substances

Biomarkers
Cysteine Proteases
Cysteine Endopeptidases
asparaginylendopeptidase